Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 11, 2022

SELL
$42.05 - $47.77 $11,605 - $13,184
-276 Reduced 2.63%
10,212 $443,000
Q1 2022

May 12, 2022

BUY
$40.23 - $47.74 $28,603 - $33,943
711 Added 7.27%
10,488 $456,000
Q4 2021

Feb 14, 2022

BUY
$38.88 - $45.31 $32,076 - $37,380
825 Added 9.22%
9,777 $433,000
Q3 2021

Nov 04, 2021

SELL
$38.79 - $43.16 $20,791 - $23,133
-536 Reduced 5.65%
8,952 $343,000
Q2 2021

Aug 13, 2021

BUY
$36.52 - $41.46 $22,751 - $25,829
623 Added 7.03%
9,488 $385,000
Q1 2021

May 14, 2021

SELL
$34.27 - $40.01 $77,792 - $90,822
-2,270 Reduced 20.39%
8,865 $319,000
Q4 2020

Feb 12, 2021

BUY
$34.07 - $39.94 $24,223 - $28,397
711 Added 6.82%
11,135 $412,000
Q3 2020

Nov 13, 2020

BUY
$38.11 - $42.99 $11,890 - $13,412
312 Added 3.09%
10,424 $393,000
Q2 2020

Aug 07, 2020

SELL
$37.87 - $43.58 $45,406 - $52,252
-1,199 Reduced 10.6%
10,112 $417,000
Q1 2020

May 14, 2020

BUY
$32.47 - $48.83 $2,662 - $4,004
82 Added 0.73%
11,311 $428,000
Q4 2019

Feb 14, 2020

SELL
$42.0 - $48.25 $14,994 - $17,225
-357 Reduced 3.08%
11,229 $526,000
Q3 2019

Nov 15, 2019

SELL
$40.46 - $43.52 $10,074 - $10,836
-249 Reduced 2.1%
11,586 $498,000
Q2 2019

Aug 13, 2019

SELL
$39.4 - $42.7 $55,948 - $60,634
-1,420 Reduced 10.71%
11,835 $473,000
Q1 2019

May 14, 2019

SELL
$38.57 - $42.69 $94,573 - $104,675
-2,452 Reduced 15.61%
13,255 $559,000
Q4 2018

Feb 14, 2019

SELL
$37.8 - $42.69 $148,138 - $167,302
-3,919 Reduced 19.97%
15,707 $604,000
Q3 2018

Nov 16, 2018

SELL
$39.75 - $42.69 $11,766 - $12,636
-296 Reduced 1.49%
19,626 $786,000
Q2 2018

Aug 15, 2018

SELL
$39.61 - $42.76 $1,980 - $2,138
-50 Reduced 0.25%
19,922 $807,000
Q1 2018

May 16, 2018

BUY
$36.18 - $40.15 $74,422 - $82,588
2,057 Added 11.48%
19,972 $780,000
Q4 2017

Feb 16, 2018

BUY
$35.34 - $41.9 $633,116 - $750,638
17,915
17,915 $635,000

Others Institutions Holding GSK

About GSK PLC


  • Ticker GSK
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,033,689,984
  • Market Cap $69.2B
  • Description
  • GSK plc, together with its subsidiaries, engages in the creation, discovery, development, manufacture, and marketing of pharmaceutical products, vaccines, over-the-counter medicines, and health-related consumer products in the United Kingdom, the United States, and internationally. It operates through four segments: Pharmaceuticals, Pharmaceutic...
More about GSK
Track This Portfolio

Track Banco De Sabadell, S.A Portfolio

Follow Banco De Sabadell, S.A and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Banco De Sabadell, S.A, based on Form 13F filings with the SEC.

News

Stay updated on Banco De Sabadell, S.A with notifications on news.